Pancreatic Cancer Research

ResearcherJapan Society for the Promotion of ScienceActive in the last 2 years

Takahiro Seimiya

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1698-0309; OpenAlex author ID A5008385611. Sources: OpenAlex.

Their work

Papers
11
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 3 papers · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 11

  1. Association between Serum Human Satellite II RNA and miR-21-5p Levels and Time to Pancreatic Cancer Diagnosis in a Prospective Population-based Study. Co-author DOI 10.1097/mpa.0000000000002723↗
  2. WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway. Co-author DOI 10.1007/s00535-024-02192-x↗
  3. CA19-9-Positive Extracellular Vesicle Is a Risk Factor for Cancer-Associated Thrombosis in Pancreatic Cancer. Co-author DOI 10.1016/j.gastha.2024.02.005↗
  4. Satellite double-stranded RNA induces mesenchymal transition in pancreatic cancer by regulating alternative splicing. Co-author DOI 10.1016/j.jbc.2024.105742↗
  5. Combination of serum human satellite RNA and miR-21-5p levels as a biomarker for pancreatic cancer. Co-author DOI 10.1016/j.isci.2023.106021↗
  6. Lipolysis by pancreatic cancer-derived extracellular vesicles in cancer-associated cachexia via specific integrins. Co-author DOI 10.1002/ctm2.1089↗
  7. Smaller extracellular vesicles are released from pancreatic cancer cells by the alteration of the lipid composition under low glucose conditions. Co-author DOI 10.1016/j.bbrc.2022.11.040↗
  8. Roles of circular RNAs in the pathogenesis and treatment of pancreatic cancer. Co-author DOI 10.3389/fcell.2022.1023332↗
  9. Aberrant expression of a novel circular RNA in pancreatic cancer. Co-author DOI 10.1038/s10038-020-00826-5↗
  10. The biological role of metabolic reprogramming in pancreatic cancer. Co-author DOI 10.1002/mco2.37↗
  11. Satellite RNA Increases DNA Damage and Accelerates Tumor Formation in Mouse Models of Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-18-0139↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Motoyuki Otsuka · 11 shared papers, 2018–2026 · strength 2.04
  2. Takahiro Kishikawa · 9 shared papers, 2018–2026 · strength 1.65
  3. Mitsuhiro Fujishiro · 7 shared papers, 2022–2026 · strength 1.55
  4. Chikako Shibata · 7 shared papers, 2021–2026 · strength 1.33
  5. Takuma Iwata · 5 shared papers, 2020–2025 · strength 0.82
  6. Kazunaga Ishigaki · 4 shared papers, 2022–2024 · strength 0.76
  7. Genso Notoya · 3 shared papers, 2024–2026 · strength 0.67
  8. Kazuhiko Koike · 5 shared papers, 2018–2024 · strength 0.67
  9. Tatsunori Suzuki · 4 shared papers, 2018–2024 · strength 0.54
  10. Yousuke Nakai · 2 shared papers, 2023–2026 · strength 0.40
  11. Hideaki Ijichi · 2 shared papers, 2023–2025 · strength 0.38
  12. Keitaro Matsuo · 1 shared paper, 2026 · strength 0.26
  13. Ryota Takahashi · 1 shared paper, 2025 · strength 0.24
  14. Koji Miyabayashi · 1 shared paper, 2025 · strength 0.24
  15. Keisuke Yamamoto · 1 shared paper, 2025 · strength 0.24
  16. Hiroki Oyama · 1 shared paper, 2023 · strength 0.14
  17. Reo Maruyama · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.